GWS
IDXX icon

Greykasell Wealth Strategies’s Idexx Laboratories IDXX Stock Holding History

Greykasell Wealth Strategies’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.5K Sell
75
-1
-1% -$561 0.01% 248
2026
Q1 		$42.7K Buy
76
+21
+38% +$13.5K 0.02% 257
2025
Q4 		$37.2K Hold
55
– – 0.01% 263
2025
Q3 		$35.1K Buy
+55
New +$33.4K 0.01% 225

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Greykasell Wealth Strategies's IDXX Position: Q2 2026 in Review

Greykasell Wealth Strategies reduced its Idexx Laboratories (IDXX) stake by 1.3% in Q2 2026, selling an estimated $561 and leaving 75 shares worth $39.5K. The position accounts for 0.01% of the portfolio, ranked #248.

Greykasell Wealth Strategies first reported a position in IDXX in Q3 2025 and has held it in 4 quarters since. The position peaked at $42.7K in Q1 2026. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Greykasell Wealth Strategies held 75 shares of Idexx Laboratories worth $39.5K as of Q2 2026.
  • Greykasell Wealth Strategies sold 1 Idexx Laboratories share in Q2 2026, an estimated $561.
  • Idexx Laboratories made up 0.01% of Greykasell Wealth Strategies's portfolio in Q2 2026, its #248 holding.
  • Greykasell Wealth Strategies first reported a position in Idexx Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Greykasell Wealth Strategies's Idexx Laboratories position peaked at $42.7K in Q1 2026.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q2 2026, filed 11 Aug 2026.